Men with localised prostate cancer have high long-term survival rates regardless of whether they choose a ‘watch and wait’ approach or radical treatment, a landmark study shows.

Although prostatectomy and radiotherapy cut the incidence of metastasis and local progression by half compared to active monitoring, UK researchers say these reductions did not translate to a mortality benefit.